LISTEN HERE:
Major changes have arrived in the U.S. COVID-19 vaccination landscape, as the government shifts its focus toward updated, more straightforward vaccine recommendations. As a result, the original vaccines from Pfizer and Moderna, which once served as the primary defense against the virus for many, have become a thing of the past.
The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
— U.S. FDA (@US_FDA) April 18, 2023
Now, anyone who has not yet received a bivalent COVID-19 booster or any coronavirus vaccination at all is eligible for a single dose of the updated shot. The Food and Drug Administration (FDA), with a few exceptions for vulnerable groups, is moving toward a one-shot vaccine regimen for people in the future.
Despite the bivalent shot receiving authorization almost eight months ago, less than a fifth of the eligible U.S. population has gotten the updated booster. Instead, many still depend on the initial series of vaccines to protect them against the SARS-CoV-2 virus.
WOW – The Moderna and Pfizer Covid 19 vaccines are NO LONGER AUTHORIZED for use in the United States.
They must be finding more and more side effects.
Who else is thankful they stood strong and didn’t get the jab? ?
— The Trump Train ??? (@The_Trump_Train) April 18, 2023
Federal officials are hopeful that this new strategy will increase vaccine coverage throughout the country. They point out that a majority of Americans likely have COVID-19 antibodies already from past infections or immunizations, which should enhance overall immunity.
Vaccination rates for follow-up COVID boosters have consistently dropped after each round. Meanwhile, federal regulators disclosed on Tuesday that a newer version of the COVID-19 vaccine, intended to better match current circulating strains, is anticipated in autumn.
Some individuals, particularly those who prioritize staying up-to-date on vaccines, may prefer to hold off until this next version becomes available. This would allow them to avoid the inconvenience of multiple doses spaced months apart.
So the covid vaccine I refused to take and lost my career over is no longer authorized for use in the USA…
— MrUseCase ??? (@MrUseCase) April 19, 2023
To streamline future immunizations, the FDA issued revised guidance on COVID-19 vaccinations on Tuesday. A key component of the new strategy involves recommending a single dose of the bivalent vaccines from Pfizer and Moderna for most people. Health and Human Services Secretary Xavier Becerra also emphasized the importance of Hispanic families proactively addressing mental health to tackle the challenges that have long hindered the proper diagnosis and treatment of mental illnesses in their community.
https://twitter.com/FletcherJersey/status/1648560106215186438?s=20
